Next-generation smallpox vaccine being stockpiled

(AP) -- A Danish company has delivered the first 1 million doses of a next-generation smallpox vaccine to the U.S. national stockpile, a vaccine reserved for people with weakened immune systems.

The federal government has ordered 20 million doses of Bavarian Nordic's Imvamune, a vaccine developed in part with U.S. research money as part of the nation's preparations in case of a bioterrorist attack.

The government has long stockpiled against such a possibility. But the conventional vaccine, made with a live virus that's a relative of , isn't safe for people with weakened immune systems. Imvamune is made of a different strain of the virus, targeted for the immune-compromised because it cannot multiply in human cells.


Explore further

Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?

©2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: Next-generation smallpox vaccine being stockpiled (2010, July 13) retrieved 12 April 2021 from https://medicalxpress.com/news/2010-07-next-generation-smallpox-vaccine-stockpiled.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments